Ofev (nintedanib) receives positive recommendation from CADTH and INESSS for the treatment of progressive fibrosing interstitial lung diseases

4 March 2021 - Ofev is the first treatment available in Canada for chronic fibrosing interstitial lung diseases with a progressive ...

Read more →

Health Canada approves Brukinsa (zanubrutinib) for the treatment of Waldenström’s macroglobulinaemia

2 March 2021 - Approval is based on the Phase 3 ASPEN trial of Brukinsa compared to ibrutinib. ...

Read more →

EMA and Health Canada publish clinical data used to support their authorisations of the Moderna COVID-19 vaccine

2 March 2021 - Openness and transparency are key to building confidence in COVID-19 vaccines. Today, EMA and Health Canada ...

Read more →

Health Canada approves AstraZeneca's COVID-19 vaccine

26 February 2021 - Canada's regulator estimates vaccine's efficacy at 62.1 per cent. ...

Read more →

Emgality (galcanezumab) now approved for use in Canada for the treatment of episodic cluster headache

25 February 2021 - The first and only anti-CGRP treatment with dual indications. ...

Read more →

Medexus announces expanded availability of Gleolan in Canada

25 February 2021 - Medexus Pharmaceuticals announced today that it has initiated the commercial launch of Gleolan in Canada, which had ...

Read more →

AbbVie’s Skyrizi for the treatment of moderate to severe plaque psoriasis now publicly reimbursed across Canada

24 February 2021 - Prince Edward Island lists Skyrizi on its Pharmacare Formulary effective 22 February 2021. ...

Read more →

Bladder cancer drug shortage resolved with Health Canada approval

24 February 2021 - Verity-BCG bladder cancer treatment available for Canadian patients in the spring. ...

Read more →

Health Canada approves Dupixent (dupilumab) as the first biologic for the treatment of moderate to severe atopic dermatitis in children aged 6 to 11 years

23 February 2021 - Dupixent is the only biologic medicine approved to treat atopic dermatitis for this patient population. ...

Read more →

Ontario makes commitment to funding CF drugs after approval process completed

19 February 2021 - Ontario’s Health Minister Christine Elliott says life-saving cystic fibrosis medications that are inching their way through ...

Read more →

Where is AstraZeneca’s vaccine? Health Canada says not yet ready to greenlight

18 February 2021 - Health Canada is not yet ready to make a decision about approving the COVID-19 vaccine from ...

Read more →

Viatris launches Hulio (adalimumab biosimilar) in Canada

18 February 2021 - Viatris announced today that Health Canada has approved Hulio, and product is now available in Canada. ...

Read more →

Fresenius Kabi Canada launches Idacio (adalimumab injection) a biosimilar to Humira (adalimumab) for the treatment of multiple chronic inflammatory conditions

18 February 2021 - Biosimilars offer patients access to affordable, meaningful medicines ...

Read more →

HLS Therapeutics provides update on private and public payer reimbursement for Vascepa

16 February 2021 - Active negotiations have also begun with the pan-Canadian Pharmaceutical Alliance for reimbursement of Vascepa by publicly funded ...

Read more →

Ultragenyx announces approval of Dojolvi (UX007/triheptanoin) in Canada for the treatment of long-chain fatty acid oxidation disorders in adults and children

17 February 2021 - First approved treatment for adult and paediatric patients with long-chain fatty acid oxidation disorders in Canada. ...

Read more →